NRXS

Neuraxis (NRXS)

Neuraxis Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:NRXS

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/07	22 : 00	GlobeNewswire Inc.	NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure	AMEX:NRXS	Neuraxis Inc
2024/05/22	21 : 00	GlobeNewswire Inc.	NeurAxis Reports First Quarter 2024 Financial Results	AMEX:NRXS	Neuraxis Inc
2024/05/21	22 : 00	GlobeNewswire Inc.	NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024	AMEX:NRXS	Neuraxis Inc
2024/05/21	05 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
2024/05/16	22 : 00	GlobeNewswire Inc.	NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida	AMEX:NRXS	Neuraxis Inc
2024/05/16	05 : 30	GlobeNewswire Inc.	NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024	AMEX:NRXS	Neuraxis Inc
2024/05/16	05 : 15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	AMEX:NRXS	Neuraxis Inc
2024/04/23	22 : 00	GlobeNewswire Inc.	NeurAxis Announces New Medical Policy Coverage in North Dakota	AMEX:NRXS	Neuraxis Inc
2024/04/10	05 : 05	GlobeNewswire Inc.	NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
2024/04/02	05 : 15	GlobeNewswire Inc.	NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024	AMEX:NRXS	Neuraxis Inc
2024/03/27	22 : 00	GlobeNewswire Inc.	NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry	AMEX:NRXS	Neuraxis Inc
2024/03/11	22 : 00	GlobeNewswire Inc.	NeurAxis Announces Highmark BCBS Policy Coverage	AMEX:NRXS	Neuraxis Inc
2024/03/11	21 : 50	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2024/03/04	23 : 00	GlobeNewswire Inc.	NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage	AMEX:NRXS	Neuraxis Inc
2024/02/28	01 : 00	GlobeNewswire Inc.	NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference	AMEX:NRXS	Neuraxis Inc
2024/02/16	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2024/01/31	23 : 15	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2023/12/20	23 : 00	GlobeNewswire Inc.	NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer	AMEX:NRXS	Neuraxis Inc
2023/12/20	07 : 05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:NRXS	Neuraxis Inc
2023/12/20	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2023/11/21	07 : 30	GlobeNewswire Inc.	NeurAxis Reports Third Quarter 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
2023/11/21	07 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
2023/11/15	23 : 00	GlobeNewswire Inc.	NeurAxis Announces CareFirst BCBS Policy Coverage	AMEX:NRXS	Neuraxis Inc
2023/11/14	23 : 00	GlobeNewswire Inc.	NeurAxis Secures $3 Million Financing	AMEX:NRXS	Neuraxis Inc
2023/11/08	23 : 00	GlobeNewswire Inc.	NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device	AMEX:NRXS	Neuraxis Inc
2023/09/26	22 : 00	GlobeNewswire Inc.	NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders	AMEX:NRXS	Neuraxis Inc
2023/09/23	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
2023/09/21	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2023/09/21	21 : 00	GlobeNewswire Inc.	NeurAxis Reports Second Quarter 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
2023/09/14	05 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:NRXS	Neuraxis Inc